Financials Cansortium Inc. OTC Markets

Equities

CNTMF

CA13809L1094

Healthcare Facilities & Services

Market Closed - OTC Markets 12:53:48 2024-07-03 EDT 5-day change 1st Jan Change
0.125 USD +1.13% Intraday chart for Cansortium Inc. -10.71% +40.45%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 88.42 154.2 167 31.89 26.96 35.94 -
Enterprise Value (EV) 1 88.42 154.2 167 31.89 26.96 35.94 35.94
P/E ratio -1.26 x -4.22 x -8.25 x -0.8 x - - -
Yield - - - - - - -
Capitalization / Revenue 3.1 x 2.94 x 2.55 x 0.36 x 0.28 x 0.34 x 0.3 x
EV / Revenue 3.1 x 2.94 x 2.55 x 0.36 x 0.28 x 0.34 x 0.3 x
EV / EBITDA -12.7 x 15 x 8.52 x 1.27 x 0.99 x 1.2 x 0.92 x
EV / FCF - -20.6 x - - - 5.13 x 2 x
FCF Yield - -4.86% - - - 19.5% 50.1%
Price to Book - - - - - - -
Nbr of stocks (in thousands) 200,954 202,904 253,049 265,778 299,529 299,529 -
Reference price 2 0.4400 0.7600 0.6600 0.1200 0.0900 0.1200 0.1200
Announcement Date 5/19/20 4/30/21 6/14/22 5/1/23 4/29/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net sales 1 28.51 52.39 65.44 87.69 97.29 106 119
EBITDA 1 -6.936 10.3 19.59 25.06 27.18 30 39
EBIT -30.86 -8.414 -0.643 - - - -
Operating Margin -108.24% -16.06% -0.98% - - - -
Earnings before Tax (EBT) -61.48 -30.4 -11.36 - - - -
Net income -65.33 -36.62 -19.04 - - - -
Net margin -229.15% -69.9% -29.1% - - - -
EPS -0.3500 -0.1800 -0.0800 -0.1500 - - -
Free Cash Flow 1 - -7.497 - - - 7 18
FCF margin - -14.31% - - - 6.6% 15.13%
FCF Conversion (EBITDA) - - - - - 23.33% 46.15%
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 5/19/20 4/30/21 6/14/22 5/1/23 4/29/24 - -
1USD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 18.28 - 22.1 23.46 22.06 24.43 25.26 25.54 25.23 27 28 26
EBITDA 1 5.11 - 11.74 7.9 9.706 8.564 8.758 0.155 6.785 8 8 7
EBIT 0.135 - 1.181 - - - - - - - - -
Operating Margin 0.74% - 5.34% - - - - - - - - -
Earnings before Tax (EBT) 6.496 - - - - - - - - - - -
Net income 3.716 -12.01 - - - - - - - - - -
Net margin 20.32% - - - - - - - - - - -
EPS 0.0200 - - -0.0300 - - - - - - - -
Dividend per Share - - - - - - - - - - - -
Announcement Date 6/14/22 8/29/22 11/29/22 5/1/23 5/30/23 8/28/23 11/29/23 4/29/24 5/30/24 - - -
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - -7.5 - - - 7 18
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex - 5.19 - - - - -
Capex / Sales - 9.91% - - - - -
Announcement Date 5/19/20 4/30/21 6/14/22 5/1/23 4/29/24 - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.12 USD
Average target price
0.7 USD
Spread / Average Target
+483.33%
Consensus

Quarterly revenue - Rate of surprise